| UniProt ID | GATA2_HUMAN | |
|---|---|---|
| UniProt AC | P23769 | |
| Protein Name | Endothelial transcription factor GATA-2 | |
| Gene Name | GATA2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 480 | |
| Subcellular Localization | Nucleus. | |
| Protein Description | Transcriptional activator which regulates endothelin-1 gene expression in endothelial cells. Binds to the consensus sequence 5'-AGATAG-3'.. | |
| Protein Sequence | MEVAPEQPRWMAHPAVLNAQHPDSHHPGLAHNYMEPAQLLPPDEVDVFFNHLDSQGNPYYANPAHARARVSYSPAHARLTGGQMCRPHLLHSPGLPWLDGGKAALSAAAAHHHNPWTVSPFSKTPLHPSAAGGPGGPLSVYPGAGGGSGGGSGSSVASLTPTAAHSGSHLFGFPPTPPKEVSPDPSTTGAASPASSSAGGSAARGEDKDGVKYQVSLTESMKMESGSPLRPGLATMGTQPATHHPIPTYPSYVPAAAHDYSSGLFHPGGFLGGPASSFTPKQRSKARSCSEGRECVNCGATATPLWRRDGTGHYLCNACGLYHKMNGQNRPLIKPKRRLSAARRAGTCCANCQTTTTTLWRRNANGDPVCNACGLYYKLHNVNRPLTMKKEGIQTRNRKMSNKSKKSKKGAECFEELSKCMQEKSSPFSAAALAGHMAPVGHLPPFSHSGHILPTPTPIHPSSSLSFGHPHPSSMVTAMG | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 71 | Phosphorylation | AHARARVSYSPAHAR HHHHCCEECCCCHHH | 17.84 | 20068231 | |
| 72 | Phosphorylation | HARARVSYSPAHARL HHHCCEECCCCHHHC | 18.80 | 20068231 | |
| 73 | Phosphorylation | ARARVSYSPAHARLT HHCCEECCCCHHHCC | 14.22 | 23401153 | |
| 86 | Asymmetric dimethylarginine | LTGGQMCRPHLLHSP CCCCCCCCCHHCCCC | 19.14 | - | |
| 86 | Methylation | LTGGQMCRPHLLHSP CCCCCCCCCHHCCCC | 19.14 | 24129315 | |
| 102 | Acetylation | LPWLDGGKAALSAAA CCCCCHHHHHHHHHH | 35.70 | 15001660 | |
| 119 | Phosphorylation | HHNPWTVSPFSKTPL HCCCCCCCCCCCCCC | 16.92 | - | |
| 176 | Phosphorylation | HLFGFPPTPPKEVSP CCCCCCCCCCCCCCC | 53.08 | - | |
| 182 | Phosphorylation | PTPPKEVSPDPSTTG CCCCCCCCCCCCCCC | 25.36 | 25159151 | |
| 186 | Phosphorylation | KEVSPDPSTTGAASP CCCCCCCCCCCCCCC | 46.08 | 21815630 | |
| 187 | Phosphorylation | EVSPDPSTTGAASPA CCCCCCCCCCCCCCC | 34.34 | 20639409 | |
| 188 | Phosphorylation | VSPDPSTTGAASPAS CCCCCCCCCCCCCCC | 29.21 | 30576142 | |
| 192 | Phosphorylation | PSTTGAASPASSSAG CCCCCCCCCCCCCCC | 22.06 | 23401153 | |
| 192 | O-linked_Glycosylation | PSTTGAASPASSSAG CCCCCCCCCCCCCCC | 22.06 | 30379171 | |
| 195 | Phosphorylation | TGAASPASSSAGGSA CCCCCCCCCCCCCCC | 28.36 | 20639409 | |
| 196 | Phosphorylation | GAASPASSSAGGSAA CCCCCCCCCCCCCCC | 26.72 | 20639409 | |
| 197 | Phosphorylation | AASPASSSAGGSAAR CCCCCCCCCCCCCCC | 28.56 | 20639409 | |
| 201 | Phosphorylation | ASSSAGGSAARGEDK CCCCCCCCCCCCCCC | 20.17 | 30576142 | |
| 213 | Phosphorylation | EDKDGVKYQVSLTES CCCCCCEEEEEECHH | 16.25 | - | |
| 216 | Phosphorylation | DGVKYQVSLTESMKM CCCEEEEEECHHHCC | 17.66 | 23917254 | |
| 218 | O-linked_Glycosylation | VKYQVSLTESMKMES CEEEEEECHHHCCCC | 20.64 | 30379171 | |
| 218 | Phosphorylation | VKYQVSLTESMKMES CEEEEEECHHHCCCC | 20.64 | 23186163 | |
| 220 | Phosphorylation | YQVSLTESMKMESGS EEEEECHHHCCCCCC | 20.61 | 25159151 | |
| 222 | Sumoylation | VSLTESMKMESGSPL EEECHHHCCCCCCCC | 49.12 | - | |
| 276 | Phosphorylation | GFLGGPASSFTPKQR CCCCCCHHHCCHHHH | 29.17 | - | |
| 281 | Acetylation | PASSFTPKQRSKARS CHHHCCHHHHHHCCC | 56.11 | 15001660 | |
| 285 | Acetylation | FTPKQRSKARSCSEG CCHHHHHHCCCCCCC | 50.43 | 15001660 | |
| 288 | Phosphorylation | KQRSKARSCSEGREC HHHHHCCCCCCCCCC | 27.19 | 22210691 | |
| 290 | Phosphorylation | RSKARSCSEGRECVN HHHCCCCCCCCCCCC | 44.31 | 23401153 | |
| 301 | Phosphorylation | ECVNCGATATPLWRR CCCCCCCCCCCCCCC | 19.15 | 28102081 | |
| 303 | Phosphorylation | VNCGATATPLWRRDG CCCCCCCCCCCCCCC | 17.98 | 28102081 | |
| 314 | Phosphorylation | RRDGTGHYLCNACGL CCCCCCCHHHHHHHC | 17.81 | 17360941 | |
| 322 | Phosphorylation | LCNACGLYHKMNGQN HHHHHHCHHHHCCCC | 5.67 | 17360941 | |
| 334 | Acetylation | GQNRPLIKPKRRLSA CCCCCCCCHHHHHHH | 52.77 | 15001660 | |
| 336 | Acetylation | NRPLIKPKRRLSAAR CCCCCCHHHHHHHHH | 45.19 | 15001660 | |
| 340 | Phosphorylation | IKPKRRLSAARRAGT CCHHHHHHHHHHHCC | 20.33 | - | |
| 376 | Phosphorylation | VCNACGLYYKLHNVN CHHHHHHHHHHCCCC | 5.48 | - | |
| 389 | Sumoylation | VNRPLTMKKEGIQTR CCCCCCHHHHHHHHH | 42.30 | - | |
| 389 | Sumoylation | VNRPLTMKKEGIQTR CCCCCCHHHHHHHHH | 42.30 | 28112733 | |
| 389 | Acetylation | VNRPLTMKKEGIQTR CCCCCCHHHHHHHHH | 42.30 | 15001660 | |
| 390 | Acetylation | NRPLTMKKEGIQTRN CCCCCHHHHHHHHHH | 50.80 | 15001660 | |
| 395 | Ubiquitination | MKKEGIQTRNRKMSN HHHHHHHHHHHHHCC | 28.17 | 29967540 | |
| 399 | Acetylation | GIQTRNRKMSNKSKK HHHHHHHHHCCHHHH | 50.67 | 15001660 | |
| 401 | Phosphorylation | QTRNRKMSNKSKKSK HHHHHHHCCHHHHHH | 44.11 | 15837948 | |
| 403 | Acetylation | RNRKMSNKSKKSKKG HHHHHCCHHHHHHHH | 57.24 | 15001660 | |
| 405 | Acetylation | RKMSNKSKKSKKGAE HHHCCHHHHHHHHHH | 63.78 | 15001660 | |
| 406 | Acetylation | KMSNKSKKSKKGAEC HHCCHHHHHHHHHHH | 74.69 | 15001660 | |
| 408 | Acetylation | SNKSKKSKKGAECFE CCHHHHHHHHHHHHH | 65.19 | 15001660 | |
| 409 | Acetylation | NKSKKSKKGAECFEE CHHHHHHHHHHHHHH | 71.14 | 15001660 | |
| 409 | Ubiquitination | NKSKKSKKGAECFEE CHHHHHHHHHHHHHH | 71.14 | 29967540 | |
| 473 | Phosphorylation | SFGHPHPSSMVTAMG CCCCCCHHHHCCCCC | 28.21 | 25332170 | |
| 477 | Phosphorylation | PHPSSMVTAMG---- CCHHHHCCCCC---- | 11.41 | 25332170 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GATA2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GATA2_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 614172 | Immunodeficiency 21 (IMD21) | |||||
| 614038 | Lymphedema, primary, with myelodysplasia (LMPM) | |||||
| 614286 | Myelodysplastic syndrome (MDS) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...